Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

2 treatments under study, led by Verasonics Vantage 256 Ultrasound

Related Conditions

Often studied with 8 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 2 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

1Total
Not Applicable (1)

Trial Status

Not Yet Recruiting1
Completed1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (2)

Showing 2 of 2 trials
NCT07667647Not ApplicableNot Yet Recruiting

MoDi Twin Placental Imaging

NCT03579069CompletedPrimary

Ductus Venosus Doppler at 16 Weeks in Monochorial Pregnancy

Showing all 2 trials

Research Network

Common Treatments

  • Verasonics Vantage 256 Ultrasound1
  • Ductus Venosus Doppler1

Active Sponsors

  • Carilion Clinic1
  • University Hospital, Montpellier1
  • Virginia Polytechnic Institute and State University1

Top Investigators

Related Conditions

  • Pregnancy1
  • Ultrasound1
  • Ultrasound Doppler1
  • Twin Twin Transfusion Syndrome1
  • Monochorionic Diamniotic Placenta1

Activity Timeline